Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

The FDA has granted EUA to Aptitude Medical Systems’ Metrix Covid/Flu multiplex test for over-the-counter use.

Nick Slowik was rocked by stage 4 prostate cancer diagnosis. But after surgery, local high school basketball official returned to court.

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...

We recently compiled a list of the 12 Best Performing Small Cap Stocks So Far in 2025. In this article, we are going to take ...

Quest Diagnostics has agreed to acquire select assets from Fresenius Medical Care’s Spectra Laboratories, expanding its portfolio with dialysis-r ...

In a separate agreement, Quest will provide lab services for end-stage kidney disease and specialized water testing for Fresenius and its partners.

Quest Diagnostics Incorporated (DGX), headquartered in Secaucus, New Jersey, offers diagnostic testing and services globally.

Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire ...

Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with ...